Abstract
Cancer researchers and administrators have attacked the Trump administration's proposal to cut the NIH budget by nearly 20%. Researchers say that the reduction could hamstring efforts to expand immunotherapies and other novel treatments to more patients. They also worry that the proposal could drive away biomedical scientists and shift top-notch research to other countries.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
